100 related articles for article (PubMed ID: 12917635)
1. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Tauchi T; Shin-Ya K; Sashida G; Sumi M; Nakajima A; Shimamoto T; Ohyashiki JH; Ohyashiki K
Oncogene; 2003 Aug; 22(34):5338-47. PubMed ID: 12917635
[TBL] [Abstract][Full Text] [Related]
2. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
Waki K; Anno K; Ono T; Ide T; Chayama K; Tahara H
Cancer Sci; 2010 Jul; 101(7):1678-85. PubMed ID: 20456367
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host.
Amagai K; Ikeda H; Hashimoto J; Kozone I; Izumikawa M; Kudo F; Eguchi T; Nakamura T; Osada H; Takahashi S; Shin-Ya K
Sci Rep; 2017 Jun; 7(1):3382. PubMed ID: 28611443
[TBL] [Abstract][Full Text] [Related]
4. A G-quadruplex stabilizer induces M-phase cell cycle arrest.
Tsai YC; Qi H; Lin CP; Lin RK; Kerrigan JE; Rzuczek SG; LaVoie EJ; Rice JE; Pilch DS; Lyu YL; Liu LF
J Biol Chem; 2009 Aug; 284(34):22535-43. PubMed ID: 19531483
[TBL] [Abstract][Full Text] [Related]
5. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
6. Structure, Topology, and Stability of Multiple G-quadruplexes in Long Telomeric Overhangs.
Shiekh S; Kodikara SG; Balci H
J Mol Biol; 2024 Jan; 436(1):168205. PubMed ID: 37481156
[TBL] [Abstract][Full Text] [Related]
7. G-quadruplexes and associated proteins in aging and Alzheimer's disease.
Vijay Kumar MJ; Morales R; Tsvetkov AS
Front Aging; 2023; 4():1164057. PubMed ID: 37323535
[TBL] [Abstract][Full Text] [Related]
8. Stable bulged G-quadruplexes in the human genome: identification, experimental validation and functionalization.
Papp C; Mukundan VT; Jenjaroenpun P; Winnerdy FR; Ow GS; Phan AT; Kuznetsov VA
Nucleic Acids Res; 2023 May; 51(9):4148-4177. PubMed ID: 37094040
[TBL] [Abstract][Full Text] [Related]
9. Structural and Functional Classification of G-Quadruplex Families within the Human Genome.
Neupane A; Chariker JH; Rouchka EC
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980918
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) Complexes Coupled by Erianin via a Flexible Carbon Chain as a Potential Stabilizer of
Wang Z; Liu W; Li G; Wang J; Zhao B; Huang P; Mei W
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838516
[TBL] [Abstract][Full Text] [Related]
11. The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer.
Zhang L; Lu Y; Ma X; Xing Y; Sun J; Jia Y
Front Mol Biosci; 2022; 9():965924. PubMed ID: 35959461
[TBL] [Abstract][Full Text] [Related]
12. Linear consecutive hexaoxazoles as G4 ligands inducing chair-type anti-parallel topology of a telomeric G-quadruplex.
Sasaki S; Ma Y; Ishizuka T; Bao HL; Hirokawa T; Xu Y; Tera M; Nagasawa K
RSC Adv; 2020 Nov; 10(71):43319-43323. PubMed ID: 35519695
[TBL] [Abstract][Full Text] [Related]
13. DNA folds threaten genetic stability and can be leveraged for chemotherapy.
Zell J; Rota Sperti F; Britton S; Monchaud D
RSC Chem Biol; 2021 Feb; 2(1):47-76. PubMed ID: 35340894
[TBL] [Abstract][Full Text] [Related]
14. Major Achievements in the Design of Quadruplex-Interactive Small Molecules.
Mendes E; Aljnadi IM; Bahls B; Victor BL; Paulo A
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337098
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium(II) Polypyridyl Complexes and Their Use as Probes and Photoreactive Agents for G-quadruplexes Labelling.
Jiang J; Teunens T; Tisaun J; Denuit L; Moucheron C
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268640
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of higher-order DNA structures by azacryptands induces DNA junction-mediated DNA damage in cancer cells.
Zell J; Duskova K; Chouh L; Bossaert M; Chéron N; Granzhan A; Britton S; Monchaud D
Nucleic Acids Res; 2021 Oct; 49(18):10275-10288. PubMed ID: 34551430
[TBL] [Abstract][Full Text] [Related]
17. Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics.
Seimiya H; Nagasawa K; Shin-Ya K
J Antibiot (Tokyo); 2021 Oct; 74(10):617-628. PubMed ID: 34285374
[TBL] [Abstract][Full Text] [Related]
18. BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells.
De Magis A; Kastl M; Brossart P; Heine A; Paeschke K
BMC Biol; 2021 Mar; 19(1):45. PubMed ID: 33706790
[TBL] [Abstract][Full Text] [Related]
19. G-quadruplexes: a promising target for cancer therapy.
Kosiol N; Juranek S; Brossart P; Heine A; Paeschke K
Mol Cancer; 2021 Feb; 20(1):40. PubMed ID: 33632214
[TBL] [Abstract][Full Text] [Related]
20. Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.
Bhari VK; Kumar D; Kumar S; Mishra R
Biochem Biophys Rep; 2021 Jul; 26():100937. PubMed ID: 33553693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
